These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3577250)

  • 1. [Evaluation of remaining performance capacity in patients with alveolitis and pulmonary fibrosis].
    Pielesch W; Liebetrau G
    Z Erkr Atmungsorgane; 1987; 168(1):89-94. PubMed ID: 3577250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early detection of fibrosing alveolitis in collagenoses].
    Petermann W
    Z Rheumatol; 1986; 45(5):267-70. PubMed ID: 3811634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise testing in the evaluation of diffuse interstitial lung disease.
    Anderson SD; Bye PT
    Aust N Z J Med; 1984 Oct; 14(5 Suppl 3):762-8. PubMed ID: 6442561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung function disturbances in fibrosis].
    Arzt GH
    Internist (Berl); 1974 Jul; 15(7):364-9. PubMed ID: 4608156
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung diffusion estimated by oxygen and carbon monoxide.
    Hájek D; Vlcek J; Vasků A
    Acta Med Austriaca; 1998; 25(1):13-5. PubMed ID: 9576019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diffuse pulmonary fibrosis on lung mechanics.
    Murphy DM; Hall DR; Petersen MR; Lapp NL
    Bull Eur Physiopathol Respir; 1981; 17(1):27-41. PubMed ID: 7470684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The compliance-volume relationship in healthy persons and in cases of fibrosis of the lungs and pulmonary emphysema (author's transl)].
    Bugalho de Almeida AA; Telhada F; Ulmer WT
    Prax Klin Pneumol; 1980 Dec; 34(12):739-45. PubMed ID: 7465535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary manifestations of lupus erythematodes visceralis].
    Görlitz N; Berzon R; Rössner B; Wessel G; Jäckel R
    Z Rheumatol; 1976; 35(3-4):118-22. PubMed ID: 1266420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic pulmonary reaction after nitrofurantoin (author's transl)].
    Ancic P; Ferretti R
    Rev Med Chil; 1979 Apr; 107(4):319-23. PubMed ID: 504837
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary function tests in diffuse interstitial lung disease].
    Scherrer M
    Schweiz Med Wochenschr; 1970 Oct; 100(43):1829-35. PubMed ID: 5524923
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial changes in scleroderma and idiopathic interstitial lung disease.
    Colp CR; Riker J; Williams MH
    Arch Intern Med; 1973 Oct; 132(4):506-15. PubMed ID: 4742404
    [No Abstract]   [Full Text] [Related]  

  • 13. Diurnal variation in pulmonary diffusing capacity and expiratory volumes.
    Panda A; McHardy G
    Indian J Physiol Pharmacol; 1980; 24(2):112-8. PubMed ID: 7189745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of the static compliance and carbon monoxide diffusion capacity in the verification of a pulmonary fibrosis associated with silicoses].
    Mährlein W
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 135(2):217-24. PubMed ID: 5211696
    [No Abstract]   [Full Text] [Related]  

  • 15. DLCO versus DLCO/VA as predictors of pulmonary gas exchange.
    Kaminsky DA; Whitman T; Callas PW
    Respir Med; 2007 May; 101(5):989-94. PubMed ID: 17055236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic fibrosing alveolitis].
    Cegla UH
    Fortschr Med; 1977 Sep; 95(25):2157-61. PubMed ID: 914141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical function diagnosis in interstitial lung diseases].
    Bühlmann AA
    Verh Dtsch Ges Inn Med; 1975; 81():359-70. PubMed ID: 1229536
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results?
    Schildge J; Nagel C; Grun C
    Respiration; 2007; 74(5):553-7. PubMed ID: 17496412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of the phase angle of respiratory impedance in patients with interstitial lung diseases].
    Kappos AD; Haseneier I; Müller U; Meier-Sydow J; Rust M
    Prax Klin Pneumol; 1986 May; 40(5):179-82. PubMed ID: 3725732
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrosing alveolitis in collagenoses and sarcoidoses. On the value of functional analytic findings in follow-ups].
    Petermann W
    Prax Klin Pneumol; 1986 Jun; 40(6):274-8. PubMed ID: 3748980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.